These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
318 related items for PubMed ID: 21742784
21. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Spandou E, Tsouchnikas I, Karkavelas G, Dounousi E, Simeonidou C, Guiba-Tziampiri O, Tsakiris D. Nephrol Dial Transplant; 2006 Feb; 21(2):330-6. PubMed ID: 16221709 [Abstract] [Full Text] [Related]
22. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC. Kidney Int; 2006 May; 69(10):1806-13. PubMed ID: 16598197 [Abstract] [Full Text] [Related]
23. A novel specific application of pyruvate protects the mouse retina against white light damage: differential stabilization of HIF-1α and HIF-2α. Ren H, Liu NY, Song XF, Ma YS, Zhai XY. Invest Ophthalmol Vis Sci; 2011 May 11; 52(6):3112-8. PubMed ID: 21228376 [Abstract] [Full Text] [Related]
25. Reduction of obliterative bronchiolitis (OB) by prolyl-hydroxylase-inhibitors activating hypoxia-inducible transcription factors in an experimental mouse model. Heim C, Motsch B, Jalilova S, Bernhardt WM, Ramsperger-Gleixner M, Burzlaff N, Weyand M, Eckardt KU, Ensminger SM. Transpl Immunol; 2016 Nov 11; 39():66-73. PubMed ID: 27590486 [Abstract] [Full Text] [Related]
31. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schödel J, Reisenbuechler A, Klaus S, Arend M, Flippin L, Willam C, Wiesener MS, Yard B, Warnecke C, Eckardt KU. Proc Natl Acad Sci U S A; 2009 Dec 15; 106(50):21276-81. PubMed ID: 19934037 [Abstract] [Full Text] [Related]
32. Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: a role for IL-6. Ramadori P, Ahmad G, Ramadori G. Lab Invest; 2010 Sep 15; 90(9):1306-24. PubMed ID: 20458283 [Abstract] [Full Text] [Related]
34. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. Hill P, Shukla D, Tran MG, Aragones J, Cook HT, Carmeliet P, Maxwell PH. J Am Soc Nephrol; 2008 Jan 15; 19(1):39-46. PubMed ID: 18178798 [Abstract] [Full Text] [Related]
35. Inhibition of prolyl hydroxylase domain-containing protein on hypertension/renal injury induced by high salt diet and nitric oxide withdrawal. Dallatu MK, Choi M, Oyekan AO. J Hypertens; 2013 Oct 15; 31(10):2043-9. PubMed ID: 23811999 [Abstract] [Full Text] [Related]
37. Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1α and iNOS involvement. Belaidi E, Beguin PC, Levy P, Ribuot C, Godin-Ribuot D. Fundam Clin Pharmacol; 2012 Aug 15; 26(4):454-62. PubMed ID: 21480981 [Abstract] [Full Text] [Related]
38. HIF-prolyl hydroxylases in the rat kidney: physiologic expression patterns and regulation in acute kidney injury. Schödel J, Klanke B, Weidemann A, Buchholz B, Bernhardt W, Bertog M, Amann K, Korbmacher C, Wiesener M, Warnecke C, Kurtz A, Eckardt KU, Willam C. Am J Pathol; 2009 May 15; 174(5):1663-74. PubMed ID: 19349364 [Abstract] [Full Text] [Related]